• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    PetMeds® Appoints Sandra Y. Campos to its Board of Directors

    5/18/23 4:01:00 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $PETS alert in real time by email

    DELRAY BEACH, Fla., May 18, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS), Your Trusted Pet Health Expert™, announced the appointment of Sandra Y. Campos to its Board of Directors effective May 17, 2023.

    "We are delighted to welcome Ms. Campos to PetMeds' board of directors," said Dr. Gian Fulgoni, Board Chairman. "Sandra's vast experience with brand management, digital transformations, and supply chain management, will undoubtedly help the Company as we continue to deliver "Nose-to-Tail" services to our pet families and continue to define the PetMeds' brand as "Your Trusted Pet Health Expert."

    Ms. Campos serves on the Boards of Big Lots, a nationwide retailer of furniture, food, and décor and Fabric, a modular and headless commerce solution. As an executive, Sandra was CEO for DVF (Diane Von Furstenberg), Co-President of the women's businesses at Global Brands Group, Co-President of Women's Apparel Group, and President of O Oscar. Ms. Campos is also a serial entrepreneur, founding the first celebrity brand management company for celebrity Selena Gomez, a CPG brand, and an edtech platform. She is a frequent keynote speaker, panelist, and regular contributor for CNBC and thought leader on topics ranging from the supply chain, leadership, retail innovation, ESG, and diversity in the workplace.

    "PetMeds' mission to be the most trusted pet health expert resonates with me," said Sandra Campos. "As an owner of many pets, the PetMeds' mission to be the most trusted pet health expert resonates with me. PetMeds has top talent at the executive and board levels that have put together all of the necessary components to fuel significant growth and provide across-the-board health services that pet parents need. I'm looking forward to helping the company deliver on the exciting opportunity provided by their recent acquisition of PetCareRx and ultimately delivering great value for our customers and stakeholders."

    ABOUT PETMEDS

    Founded in 1996, PetMeds is Your Trusted Pet Health Expert, delivering pet medications, food, health services and other products direct to the consumer at PetMeds.com and through its toll-free number (1-800-PetMeds). PetMeds aims to be the most trusted pet health expert by providing incredible care and services that are affordable to the broadest group of pet parents--because every pet deserves to live a long, happy, healthy life. For more information, please visit www.petmeds.com.

    PETMEDS MEDIA CONTACT

    Mary Eva Tredway

    Butin PR

    [email protected]

    PETMEDS INVESTOR RELATIONS CONTACT

    Brian M. Prenoveau, CFA

    MZ Group

    561-489-5315

    [email protected]



    Primary Logo

    Get the next $PETS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PETS

    DatePrice TargetRatingAnalyst
    5/25/2023$20.00Buy
    Lake Street
    1/25/2022$25.00 → $21.00Underweight
    Morgan Stanley
    1/20/2022$32.00Neutral → Buy
    Sidoti
    11/18/2021$25.00Underweight
    Morgan Stanley
    10/1/2021$28.00Hold
    Jefferies
    8/5/2021$22.00Underperform
    Credit Suisse
    More analyst ratings

    $PETS
    SEC Filings

    View All

    PetMed Express Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - PETMED EXPRESS INC (0001040130) (Filer)

    8/12/25 4:20:55 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form NT 10-Q filed by PetMed Express Inc.

    NT 10-Q - PETMED EXPRESS INC (0001040130) (Filer)

    8/11/25 4:34:45 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

    8-K - PETMED EXPRESS INC (0001040130) (Filer)

    7/3/25 8:36:16 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Silvercape Investments Ltd bought $320,170 worth of shares (101,000 units at $3.17), increasing direct ownership by 4% to 2,579,696 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    8/14/25 8:40:29 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Large owner Silvercape Investments Ltd bought $379,422 worth of shares (118,200 units at $3.21), increasing direct ownership by 5% to 2,478,696 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    8/4/25 8:26:23 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Large owner Nina Capital Holdings Inc. bought $87,425 worth of shares (25,000 units at $3.50), increasing direct ownership by 0.98% to 2,575,000 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    7/22/25 4:15:16 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PetMed Express, Inc. Announces Management Changes

    DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the "Company") dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D'Elia, have resigned from their positions and employment with the Company. As part of the leadership changes, Leslie C.G. Campbell, the Chair of the Company's Board of Directors (the "Board"), has assumed the role of Interim Chief Executive Officer, and Douglas Krulik, the Company's Chief Accounting Officer, has assumed the role of Interim Principal Financial Officer. The Company has initiated a search for a new Chief Executive Officer and Chi

    8/12/25 4:11:13 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMeds Partners with myBalto Foundation to Raise Nearly $45,000 to Alleviate Financial Stress Pet Owners Face with Emergency Vet Bills

    DELRAY BEACH, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS) today announced that it partnered with the myBalto Foundation for its recent "Top of the Class" fundraising drive, resulting in nearly $45,000 in donations. myBalto is a leading platform dedicated to empowering veterinary hospitals to support pets with critical veterinary care. Its Foundation offers veterinary hospitals a free Angel Fund, eliminating the administrative burdens of setting up and managing a traditional charity, to help pet parents in need pay for emergency veterinarian costs. "PetMeds is proud to stand alongside organizations like myBalto Foundation that are expanding acces

    7/23/25 8:00:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

    DELRAY BEACH, Fla., July 03, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS) received on July 2, 2025, an expected notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the "Form 10-K"), with the Securities and Exchange Commission ("SEC"), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires timely filing of all required periodic financial reports with the SEC. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. The Notice

    7/3/25 8:30:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on PetMed Express with a new price target

    Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00

    5/25/23 9:17:49 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Morgan Stanley reiterated coverage on PetMed Express with a new price target

    Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously

    1/25/22 10:17:17 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express upgraded by Sidoti with a new price target

    Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00

    1/20/22 9:13:56 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Silvercape Investments Ltd bought $320,170 worth of shares (101,000 units at $3.17), increasing direct ownership by 4% to 2,579,696 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    8/14/25 8:40:29 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Large owner Silvercape Investments Ltd bought $379,422 worth of shares (118,200 units at $3.21), increasing direct ownership by 5% to 2,478,696 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    8/4/25 8:26:23 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Large owner Nina Capital Holdings Inc. bought $87,425 worth of shares (25,000 units at $3.50), increasing direct ownership by 0.98% to 2,575,000 units (SEC Form 4)

    4 - PETMED EXPRESS INC (0001040130) (Issuer)

    7/22/25 4:15:16 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Financials

    Live finance-specific insights

    View All

    PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25

    DELRAY BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced preliminary fourth quarter and fiscal year 2025 results and filed Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 within the prescribed time period without unreasonable effort or expense. The Company expects to file its Annual Report on Form 10-K with the Securities and Exchange Commission as soon as practicable, and no later than July 1, 2025, in accordance with Rule 12b-25. Preliminary Fourth Quarter

    6/16/25 8:30:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call

    DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process. The Company anticipates that it will issue the earnings release, hold the related conference call, and file its Annual Report on Form 10-K as soon as possible, but no later than June 16, 2025. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in pioneering the digital pet p

    6/10/25 4:05:00 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call

    DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562We

    5/27/25 4:05:00 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PetMed Express Inc.

    SC 13G - PETMED EXPRESS INC (0001040130) (Subject)

    11/14/24 4:02:14 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G filed by PetMed Express Inc.

    SC 13G - PETMED EXPRESS INC (0001040130) (Subject)

    10/10/24 6:26:43 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by PetMed Express Inc. (Amendment)

    SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)

    2/13/24 5:12:03 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $PETS
    Leadership Updates

    Live Leadership Updates

    View All

    PetMeds Partners with myBalto Foundation to Raise Nearly $45,000 to Alleviate Financial Stress Pet Owners Face with Emergency Vet Bills

    DELRAY BEACH, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS) today announced that it partnered with the myBalto Foundation for its recent "Top of the Class" fundraising drive, resulting in nearly $45,000 in donations. myBalto is a leading platform dedicated to empowering veterinary hospitals to support pets with critical veterinary care. Its Foundation offers veterinary hospitals a free Angel Fund, eliminating the administrative burdens of setting up and managing a traditional charity, to help pet parents in need pay for emergency veterinarian costs. "PetMeds is proud to stand alongside organizations like myBalto Foundation that are expanding acces

    7/23/25 8:00:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th

    DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ:PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025. This momentous occasion honors the powerful bond between people and their pets and will feature adoptable rescue dogs from Bidawee, one of the nation's oldest no-kill animal welfare organizations. It's a tribute to the joy and unconditional love pets bring into our lives–and a reminder of how many still await families of their own. "Our pets are more than just animals; they are family," said Sandra Campo

    4/11/25 9:00:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors

    Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the Board since 2024 Longtime board member and former Chairman Dr. Gian Fulgoni will retire DELRAY BEACH, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Peter Batushansky to the Company's Board of Directors ("the Board"), effective April 09, 2025. Mr. Batushansky is currently a Partner at L2 Capital Partners and brings to the Board more than 20 years of experience across retail, pet, healthcare and private equity, i

    4/9/25 8:00:00 AM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples